Holen Sie sich die Stockscreener-App
9.935
0.42%
0.085
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AVXL?
Forum
Prognose
Aktiensplit
Anavex Life Sciences Corporation Aktie (AVXL) Neueste Nachrichten
Long-Term investors in shares of Anavex Life Sciences Corp. - openPR
Best Momentum Stocks to Buy for January 21st - Yahoo Finance
Anavex Life Sciences (NASDAQ:AVXL) Earns Buy Rating from HC Wainwright - MarketBeat
New Strong Buy Stocks for January 21st - Yahoo Finance
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz - MSN
Anavex Life Sciences (NASDAQ:AVXL) Stock Price Up 9.4%What's Next? - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Shares Down 6.3%Time to Sell? - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Shares Up 9.4%Here's Why - MarketBeat
Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer's Disease - The Manila Times
Anavex's Oral Alzheimer's Drug Shows Breakthrough 36% Disease Slowdown in Phase 3 Trial - StockTitan
Anavex Life Sciences Corp. (NASDAQ:AVXL) Stock Holdings Raised by Barclays PLC - MarketBeat
Barclays PLC Acquires 64,101 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Dru - Asianet Newsable
Anavex Life Sciences: Pioneering Precision Medicine for CNS Disorders - Big News Network
Anavex Life Sciences (NASDAQ:AVXL) Receives “Buy” Rating from D. Boral Capital - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Receives Buy Rating from D. Boral Capital - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) vs. Pluri (NASDAQ:PLUR) Critical Comparison - Defense World
The Misconceptions About Anavex Life Sciences' Blarcamesine Phase 2b/3 Trial In Alzheimer's Disease - Seeking Alpha
Commit To Buy Anavex Life Sciences Corp At $7, Earn 28.6% Using Options - Nasdaq
Jane Street Group LLC Sells 119,531 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - MarketBeat
Jane Street Group LLC Trims Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Trading Down 11.3%What's Next? - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Trading 6.3% HigherStill a Buy? - MarketBeat
Anavex Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Anavex Life Sciences to Present at JP Morgan Healthcare Conference 2025: Focus on Neurological Breakthroughs - StockTitan
Anavex Life Sciences (NASDAQ:AVXL) Shares Gap UpShould You Buy? - MarketBeat
Anavex Life Sciences Corp. (NASDAQ:AVXL) Short Interest Up 5.7% in December - Defense World
Franklin Resources Inc. Boosts Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Short Interest in Anavex Life Sciences Corp. (NASDAQ:AVXL) Expands By 5.7% - MarketBeat
Geode Capital Management LLC Increases Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Geode Capital Management LLC Increases Stake in Anavex Life Sciences Corp. (NASDAQ:AVXL) - MarketBeat
Are Medical Stocks Lagging Anavex Life Sciences (AVXL) This Year? - Yahoo Finance
Barclays PLC Boosts Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Acquired by Barclays PLC - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Trading Down 7.6%What's Next? - MarketBeat
All You Need to Know About Anavex Life Sciences (AVXL) Rating Upgrade to Buy - Yahoo Finance
HC Wainwright Issues Positive Estimate for AVXL Earnings - MarketBeat
HC Wainwright Has Optimistic Outlook of AVXL Q1 Earnings - Defense World
Anavex Life Sciences: Short-Squeeze Target Gains Traction - Investing.com
Anavex Life Sciences: Jumping In On Time Ahead Of An Early Alzheimer's Decision - Seeking Alpha
Anavex Life Sciences (NASDAQ:AVXL) Price Target Raised to $42.00 at HC Wainwright - Defense World
Anavex Life Sciences (NASDAQ:AVXL) vs. Autolus Therapeutics (NASDAQ:AUTL) Head-To-Head Analysis - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Trading Up 6.9% After Analyst Upgrade - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Stock Price Up 6.9% After Analyst Upgrade - MarketBeat
Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday - Benzinga
Anavex Life Sciences (NASDAQ:AVXL) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
H.C. Wainwright highlights blarcamesine’s potential, raises Anavex stock target By Investing.com - Investing.com South Africa
Anavex Life Sciences Faces Manufacturing Challenges Impacting Product Launch and Financial Stability - Yahoo Finance
We're Interested To See How Anavex Life Sciences (NASDAQ:AVXL) Uses Its Cash Hoard To Grow - Simply Wall St
State Street Corp Sells 674,409 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Sold by State Street Corp - MarketBeat
Fmr LLC Decreases Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Shares Gap Up After Earnings Beat - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Shares Gap Up After Strong Earnings - MarketBeat
Greenfire Resources, Hut 8, TeraWulf, MicroStrategy And Other Big Stocks Moving Higher On Tuesday - Benzinga
Anavex Life Sciences: Why I Am Still Not Buying The Bull Thesis (NASDAQ:AVXL) - Seeking Alpha
0.75%
8.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):